Inhibitory effects of alendronate on cholinergic responses in rat lower esophageal sphincter

European Journal of Pharmacology

Volumn 537, Issue 1-3, 2006, Pages 155-159

  Takeuchi, Tadayoshi ^a   Nakamura, Aki ^a   Nakajima, Hidemitsu ^a   Azuma, Yasu Taka ^a   Hata, Fumiaki ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

Alendronate; Electrical field stimulation induced contraction; Lower esophageal sphincter; NO mediated relaxation

Indexed keywords

ALENDRONIC ACID; ATROPINE; N(G) NITROARGININE; PROSTAGLANDIN F2 ALPHA;

ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC FIELD; ELECTROSTIMULATION; INHIBITION KINETICS; LOWER ESOPHAGUS SPHINCTER; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ALENDRONATE; ANIMALS; BONE DENSITY CONSERVATION AGENTS; CHOLINERGIC ANTAGONISTS; ELECTRIC STIMULATION; ESOPHAGEAL SPHINCTER, LOWER; GASTRIC FUNDUS; ILEUM; MALE; MUSCLE CONTRACTION; RATS; RATS, WISTAR;

EID: 33646151626     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.03.027     Document Type: Article

References (24)

1. Adachi J.D., Saag K.G., Delmas P.D., Liberman U.A., Emkey R.D., Seeman E., Lane N.E., Kaufman J.M., Poubelle P.E., Hawkins F., Correa-Rotter R., Menkes C.J., Rodriguez-Portales J.A., Schnitzer T.J., Block J.A., Wing J., McIlwain H.H., Westhovens R., Brown J., Melo-Gomes J.A., Gruber B.L., Yanover M.J., Leite M.O., Siminoski K.G., Nevitt M.C., Sharp J.T., Malice M.P., Dumortier T., Czachur M., Carofano W., and Daifotis A. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum. 44 (2001) 202-211
2. Boeckxstaens G.E. The lower oesophageal sphincter. Neurogastroenterol. Motil. 17 Suppl 1 (2005) 13-21
3. Bonabello A., Galmozzi M.R., Bruzzese T., and Zara G.P. Analgesic effect of bisphosphonates in mice. Pain 91 (2001) 269-275
4. Castell D.O., Murray J.A., Tutuian R., Orlando R.C., and Arnold R. Review article: the pathophysiology of gastro-oesophageal reflux disease - oesophageal manifestations. Aliment. Pharmacol. Ther. 20 Suppl 9 (2004) 14-25
5. Chang H.Y., Mashimo H., and Goyal R.K. Musings on the wanderer: what's new in our understanding of vago-vagal reflex? IV. Current concepts of vagal efferent projections to the gut. Am. J. Physiol., Gasterointest. Liver Physiol. 284 (2003) G357-G366
6. Dobrucali A., Tobey N.A., Awayda M.S., Argote C., Abdulnour-Nakhoul S., Shao W., and Orlando R.C. Physiological and morphological effects of alendronate on rabbit esophageal epithelium. Am. J. Physiol., Gasterointest. Liver Physiol. 283 (2002) G576-G586
7. Fleisch H. Bisphosphonates in Bone Disease-From the Laboratory to the Patients (2000), Academic Press, New York
8. Gertz B.J., Holland S.D., Kline W.F., Matuszewski B.K., Freeman A., Quan H., Lasseter K.C., Mucklow J.C., and Porras A.G. Studies of the oral bioavailability of alendronate. Clin. Pharmacol. Ther. 58 (1995) 288-298
9. Gonzalez A.A., Farre R., and Clave P. Different responsiveness of excitatory and inhibitory enteric motor neurons in the human esophagus to electrical field stimulation and to nicotine. Am. J. Physiol., Gasterointest. Liver Physiol. 287 (2004) G299-G306
10. Jeal W., Barradell L.B., and McTavish D. Alendronate. A review of its pharmacological properties and therapeutic efficacy in postmenopausal osteoporosis. Drugs 53 (1997) 415-434
11. Liberman U.A., Weiss S.R., Broll J., Minne H.W., Quan H., Bell N.H., Rodriguez-Portales J., Downs Jr. R.W., Dequeker J., and Favus M. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The alendronate phase III osteoporosis treatment study group. N. Engl. J. Med. 333 (1995) 1437-1443
12. Lowe C.E., Depew W.T., Vanner S.J., Paterson W.G., and Meddings J.B. Upper gastrointestinal toxicity of alendronate. Am. J. Gastroenterol. 95 (2000) 634-640
13. Nguyen N.Q., and Holloway R.H. Recent developments in esophageal motor disorders. Curr. Opin. Gastroenterol. 21 (2005) 478-484
14. Reszka A.A., and Rodan G.A. Nitrogen-containing bisphosphonate mechanism of action. Mini Rev. Med. Chem. 4 (2004) 711-719
15. Richards W.G., and Sugarbaker D.J. Neuronal control of esophageal function. Chest Surg. Clin. North Am. 5 (1995) 157-171
16. Sener G., Kapucu C., Cetinel S., Cikler E., and Ayanoglu-Dulger G. Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa. Prostaglandins Leukot. Essent. Fat. Acids 72 (2005) 1-11
17. Shao W., Orlando R.C., and Awayda M.S. Bisphosphonates stimulate an endogenous nonselective cation channel in Xenopus oocytes: potential mechanism of action. Am. J. Physiol., Cell Physiol. 289 (2005) C248-C256
18. Stevenson M., Lloyd Jones M., De Nigris E., Brewer N., Davis S., and Oakley J. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. Health Technol. Assess. 9 (2005) 1-160
19. Suri S., Monkkonen J., Taskinen M., Pesonen J., Blank M.A., Phipps R.J., and Rogers M.J. Nitrogen-containing bisphosphonates induce apoptosis of Caco-2 cells in vitro by inhibiting the mevalonate pathway: a model of bisphosphonate-induced gastrointestinal toxicity. Bone 29 (2001) 336-343
20. Toyoshima M., Takeuchi T., Goto H., Mukai K., Shintani N., Hashimoto H., Baba A., and Hata F. Roles of PACAP and PHI as inhibitory neurotransmitters in the circular muscle of mouse antrum. Pflugers Arch. 451 (2006) 559-568
21. Waseda K., Takeuchi T., Ohta M., Okishio Y., Fujita A., Hata F., and Takewaki T. Participation of ATP in nonadrenergic, noncholinergic relaxation of longitudinal muscle of wistar rat jejunum. J. Pharm. Sci. 97 (2005) 91-100
22. Watts N., Freedholm D., and Daifotis A. The clinical tolerability profile of alendronate. Int. J. Clin. Pract., Suppl. 101 (1999) 51-61
23. Yuan S., Costa M., and Brookes S.J. Neuronal pathways and transmission to the lower esophageal sphincter of the guinea pig. Gastroenterology 115 (1998) 661-671
24. Yun M.H., and Kwon K.I. High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: application to a pharmacokinetic study in humans. J. Pharm. Biomed. Anal. 40 (2006) 168-172